Overview program

An on-demand video recording of the meeting will be available for one month after the conference.

Wednesday 22nd June

14:00 (JST)
Registration
16:00 (JST)  
Opening
16:30 (JST)
Keynote Lecture

Tatsushi Toda

17:15(JST)
Keynote Lecture

Shin’ichi Takeda

18:00 (JST)    
Peter Harper Memorial Lecture

David Brook

19:00 (JST)  -20:00 (JST)
Organization Updates
Report on International DM Awareness Day
6:00AM

Thursday 23rd June

8:30 (JST)
Keynote Lecture

Gen Sobue

Session 1
Repeat-Associated Pathomechanisms
1-1 Repeat instability
9:15 (JST)
Overview

Christopher Pearson

Session 1-1

Session 1-1-1
Session 1-1-2

1-2 RNA-mediated mechanism
10:15 (JST)
Overview

Maurice Swanson

11:00 (JST)
Break
11:15 (JST)
Session 1-2

Session 1-2-1
Session 1-2-2
Session 1-2-3
Session 1-2-4

12:15 (JST)
Lunch
13:15 (JST)
Session 1-2

Session 1-2-5
Session 1-2-6
Session 1-2-7

 1-3 Cell/organoids and animal models
14:00 (JST)
 Session 1-3

Session 1-3-1
Session 1-3-2
Session 1-3-3

14:45 (JST)
Break
1-4 Tissue specific mechanisms
15:00 (JST)
 Session 1-4

Session 1-4-1
Session 1-4-2
Session 1-4-3
Session 1-4-4

16:00 (JST)
Mini Lecture 

Kazuhiko Nakatani

16:30 (JST)
Break
Session 2
Clinical Aspects
2-1  Specific disease features
16:45(JST)
Session 2-1

Session 2-1-1
Session 2-1-2
Session 2-1-3
Session 2-1-4
Session 2-1-5

18:00 (JST)
Break
2-2 Biomarkers, outcome measures, trial design, etc
18:15 (JST)
Session 2-2

Session 2-2-1
Session 2-2-2
Session 2-2-3
Session 2-2-4
Session 2-2-5

19:30 (JST) -20:00 (JST)
Overview

Baziel van Engelen

Friday 24th June

Session 3
Therapeutic Strategies and Targets
8:30 (JST)
 Session 3

Session 3-01
Session 3-02
Session 3-03
Session 3-04
Session 3-05
Session 3-06

10:00 (JST)
Break
10:15(JST)
 Session3

Session 3-07
Session 3-08
Session 3-09
Session 3-10
Session 3-11

11:30 (JST)- 12:00 (JST)
 Closing

Saturday 25th June 9:00 am (JST) IDMC-13 Families Day 

Clinical trials have already begun
-Myotonic Dystrophy: The Development of Therapeutic Drugs and the Future

Patients, families, doctors, researchers, and pharmaceutical representatives, etc. are all welcome.
https://idmc13.dm-family.net/en/